Skip to main content
UTAK Pain Management PM100 (U)

Additional Information

Safety data sheets:

UTAK Pain Management Plus

Lyophilized urine toxicology control for the quantitative determination of Pain Management drugs and their metabolites

100 % human urine matrix

Buprenorphine, Norbuprenorphine, Codeine, Norcodeine, Fentanyl, Norfentanyl, Hydrocodone, Norhydrocodone, Hydromorphone, Meperidine, Normeperidine, Methadone, Methadone Primary Metabolite (EDDP), Morphine, Monoacetylmorphine-6, Oxycodone, Noroxymycodone, Oxymorphone, Noroxymorphone, Tapentadol, N-Desmethyltapentadol, Tramadol, O-Desmethyl-cis-tramadol

Please note: Analyte composition and analyte concentration may vary with each LOT or instrument. Refer to the package insert of currently available lots for specific analyte and stability claims.



Art. No

  • UTAK REF 91000
    (5 x 5 ml)
    PM Plus Low (Pain Management)
  • UTAK REF 91002
    (5 x 5 ml)
    PM Plus High (Pain Management)


After production:
30 month at 2…8 °C

After reconstitution:
25 days at 2…8 °C